The Many Faces of Ankylosing Spondylitis: Evidence-Based Approach to Diagnosis and Management CME/CE

Author Information and Disclosures

Release Date: May 27, 2008; Valid for credit through May 27, 2009

Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians;
Nurses - 1.0 nursing contact hours (0.5 contact hours are in the area of pharmacology)

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME/CE Activity

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.
Abbott: No Tagline
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Identify the presentations of ankylosing spondylitis (AS), including nonjoint manifestations
  2. Recognize the importance of early diagnosis and aggressive management of both joint and nonjoint manifestations of AS
  3. Review the existing guidelines for treatment of AS
  4. Discuss the criteria for classification of probable and definite AS
  5. Evaluate recent data and assess the potential role of newer therapies, such as antitumor necrosis factor-alpha, in the long-term management of AS and its extra-articular manifestations
Authors and Disclosures

Muhammad A. Khan, MD, FRCP, MACP
Disclosure: Muhammad A. Khan, MD, FRCP, MACP, has disclosed that he has served as an advisor or consultant to, and as a visiting speaker for, Abbott, Amgen/Wyeth, and Centocor/Schering-Plough.


Mazen Elyan, MD
Disclosure: Mazen Elyan, MD, has disclosed no relevant financial relationships.


Helen Fosam, PhD
Disclosure: Helen Fosam, PhD, has disclosed no relevant financial relationships.


 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

 
This Activity is sponsored by Medscape Continuing Education Provider Unit.

Medscape is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education for RNs and APNs; 0.5 contact hours are in the area of pharmacology.

Provider Number: 6FDKKC-PRV-05

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.